The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom.
about
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and WalesInfluenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological, and public health concerns.The ethics of unlinked anonymous testing of blood: views from in-depth interviews with key informants in four countries.Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?Estimating adult HIV prevalence in the UK in 2003: the direct method of estimation.Prevalence of markers for HIV, hepatitis B and hepatitis C infection in UK military recruits.'Once the stuff's left my body, it's not me': service users' views on unlinked anonymous testing of blood for HIV.Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance.Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing.Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.The ethics of unlinked anonymous testing. Surveys provide essential information
P2860
Q27473418-71481E04-9AFF-402C-842A-ECF7B6B08775Q30416214-12557803-DA91-445D-8D93-F1F32BC093DFQ30935550-72056F2E-3E83-42FC-B6B9-3107E3059875Q31052065-4BC391E1-BD28-4FE7-A53F-1CECA6D516CDQ31152033-76A298A6-5B91-4BB6-920A-CA234FF9B09DQ33402586-FCFBF037-D91D-4005-9B11-2B64B2E10409Q36496139-2D9CE58D-CA9F-4F6F-B531-097440B03D06Q36928442-1EAF9CA3-069B-4D09-A17C-B368D9B89D40Q37132970-FBFCEFC2-6DF8-4F04-B7EA-DE926A35562CQ38496107-2141F5A5-5D09-4E5B-A177-81D32CAEB4E2Q38962797-F73D16F2-9701-4D4E-89F6-CAE50D9F02B5Q39775993-B776A9C7-7993-40BC-AD22-C049F265E267Q45737758-123ABECF-26CE-41B0-81E8-62783B455355Q51126531-A7386848-BAD3-42FB-85CF-41087DAEAEACQ58671488-E214BED6-D764-4297-B73C-10191DB7B2F3
P2860
The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The public health applications ...... for HIV in the United Kingdom.
@ast
The public health applications ...... for HIV in the United Kingdom.
@en
type
label
The public health applications ...... for HIV in the United Kingdom.
@ast
The public health applications ...... for HIV in the United Kingdom.
@en
prefLabel
The public health applications ...... for HIV in the United Kingdom.
@ast
The public health applications ...... for HIV in the United Kingdom.
@en
P2093
P356
P1476
The public health applications ...... for HIV in the United Kingdom.
@en
P2093
C S Peckham
D Goldberg
M Catchpole
P Mortimer
P356
10.1093/IJE/29.1.1
P577
2000-02-01T00:00:00Z